Cargando…

Complications from Surgeries Related to Ovarian Cancer Screening

The aim of this study was to evaluate complications of surgical intervention for participants in the Kentucky Ovarian Cancer Screening Program and compare results to those of the Prostate, Lung, Colorectal and Ovarian Cancer Screening trial. A retrospective database review included 657 patients who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baldwin, Lauren A., Pavlik, Edward J., Ueland, Emma, Brown, Hannah E., Ladd, Kelsey M., Huang, Bin, DeSimone, Christopher P., van Nagell, John R., Ueland, Frederick R., Miller, Rachel W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373025/ https://www.ncbi.nlm.nih.gov/pubmed/28282907 http://dx.doi.org/10.3390/diagnostics7010016

Ejemplares similares

Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer
por: Hoff, John, et al.
Publicado: (2014)

Probability of Fallopian Tube and Ovarian Detection with Transvaginal Ultrasonography in Normal Women
por: Lefringhouse, Jason R, et al.
Publicado: (2016)

Ultrasonographic Visualization of the Ovaries to Detect Ovarian Cancer According to Age, Menopausal Status and Body Type
por: Pavlik, Edward J., et al.
Publicado: (2022)

Symptoms Relevant to Surveillance for Ovarian Cancer
por: Ore, Robert M., et al.
Publicado: (2017)

Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery
por: Smith, Christopher G., et al.
Publicado: (2019)

Significance of Pelvic Fluid Observed during Ovarian Cancer Screening with Transvaginal Sonogram
por: Gorski, Justin W., et al.
Publicado: (2022)

Disease-Specific Survival of Type I and Type II Epithelial Ovarian Cancers—Stage Challenges Categorical Assignments of Indolence & Aggressiveness
por: Pavlik, Edward J., et al.
Publicado: (2020)

Assessing the Costs of Screening for Ovarian Cancer in the United States: An Evolving Analysis
por: Gorski, Justin W., et al.
Publicado: (2020)

A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come
por: Ueland, Frederick R.
Publicado: (2017)

Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology Practice
por: Rives, Taylor A., et al.
Publicado: (2023)

Hemoglobin level associates with survival in women from Appalachian Kentucky with uterine cervix cancer
por: Kunos, Charles A., et al.
Publicado: (2023)

Transvaginal ultrasonography in ovarian cancer screening: current perspectives
por: van Nagell, John R, et al.
Publicado: (2013)

Subsequent Ultrasonographic Non-Visualization of the Ovaries Is Hastened in Women with Only One Ovary Visualized Initially
por: Pavlik, Edward J., et al.
Publicado: (2022)

CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer
por: Gorski, Justin W., et al.
Publicado: (2020)

Selective Inguinal Lymphadenectomy in the Treatment of Invasive Squamous Cell Carcinoma of the Vulva
por: DeSimone, Christopher P., et al.
Publicado: (2011)

SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer
por: Harbin, Laura M., et al.
Publicado: (2023)

Ovarian Cancer Screening: Lessons about Effectiveness
por: Pavlik, Edward J.
Publicado: (2017)

Ten Important Considerations for Ovarian Cancer Screening
por: Pavlik, Edward J.
Publicado: (2017)

Radical Hysterectomy with Pelvic Lymphadenectomy: Indications, Technique, and Complications
por: Ware, Rachel A., et al.
Publicado: (2010)

Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy
por: Schweer, David, et al.
Publicado: (2022)

Salvaging Detection of Early-Stage Ovarian Malignancies When CA125 Is Not Informative
por: Dunton, Charles J., et al.
Publicado: (2021)

Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021)

Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy
por: Xu, B, et al.
Publicado: (2017)

Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance
por: Gorski, Justin W., et al.
Publicado: (2021)

Characterization of Uterine Cervix Cancers in Women from Appalachian Kentucky
por: Kunos, Charles A., et al.
Publicado: (2021)

Human epidermal growth factor receptor 2 expression in women with uterine cervix adenocarcinoma from Appalachian Kentucky
por: Kunos, Charles A., et al.
Publicado: (2023)

CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling
por: Baldwin, Lauren A., et al.
Publicado: (2014)

Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells
por: Burgess, Brian T., et al.
Publicado: (2020)

Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies
por: Wei, Ying, et al.
Publicado: (2023)

If you want to write: a book about art, independence and spirit
por: Ueland, Brenda
Publicado: (2010)

Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials
por: Ormsby, Eleanor L., et al.
Publicado: (2017)

Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer
por: McCorkle, J. Robert, et al.
Publicado: (2021)

Human macrophage-engineered vesicles for utilization in ovarian cancer treatment
por: Schweer, David, et al.
Publicado: (2023)

Psychological Response to a False Positive Ovarian Cancer Screening Test Result: Distinct Distress Trajectories and Their Associated Characteristics
por: Wiggins, Amanda T., et al.
Publicado: (2019)

Operative Approaches to Ankle and Hindfoot Arthroscopy
por: Carreira, Dominic S., et al.
Publicado: (2020)

Molecular Biomarkers in Thyroid Eye Disease: A Literature Review
por: Ueland, Hans Olav, et al.
Publicado: (2023)

Perspectives on Ovarian Cancer 1809 to 2022 and Beyond
por: Lawton, Frank G., et al.
Publicado: (2022)

DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden
por: Riggs, McKayla J., et al.
Publicado: (2020)

Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment
por: McDowell, Anthony, et al.
Publicado: (2021)

Increased levels of NT-proBNP and troponin T 2 years after coronary artery bypass grafting complicated by mediastinitis
por: Risnes, Ivar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ra3m3ogcgfum3n79pgna6k5140